Arkolith/Insider Trading/CBIO/Form 4

Fairmount Funds Management LLC

Director, 10% OwnerCRESCENT BIOPHARMA, INC. (CBIO) · full profile →Form 4 · filed Jul 20, 2026
Net Buying
Open-Market Buys
$12.4M
Open-Market Sells
$0
Net Open-Market Flow
$12.4M
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 16, 2026Buy(P)853K$14.50$12.4M3.6M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 16, 2026Buy(P)526K$14.50$7.6M2.3M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-085113) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML